IL-2,CD226PD-L) 1CMVCD8+T

Hye-In Sim1, Yunju Jo1, Hyejin Ahn2

  • 1Chemical and Biological Integrative Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792; Department of Life Sciences, Korea University, Seoul 02481, Korea.

BMB reports
|August 29, 2025
PubMed
概括

通过增加确认和利益冲突声明,该错误纠正了之前的出版物. 最初的研究研究了增强细胞巨核病毒 (CMV) 特定的CD8+ T细胞反应.